BioSpace News Archive

Dr. Reddy’s Laboratories Ltd. announced the launch of Methylprednisolone Sodium Succinate for Injection, USP, the generic equivalent of SOLU-MEDROL® in the U.S. Market approved by the U.S. Food and Drug Administration.

Oncorus, Inc. announced that it has entered into a loan and security agreement with K2 HealthVentures, a healthcare focused specialty finance company.

IRADIMED CORPORATION announced that the Company will release its 2022 first quarter financial results before the market opens on Friday, April 29th.

Tiziana Life Sciences announced that its collaborators at the Brigham and Women’s Hospital Boston MA have received a ‘Study May Proceed Letter’ from the U.S. Food and Drug Administration permitting initiation of treatment in up to an additional eight SPMS patients as part of an Intermediate-Size Patient Population Expanded Access IND.

Sutro Biopharma, Inc. announced that Bill Newell, Chief Executive Officer, will present at the 21st Annual Needham Virtual Healthcare Conference on Thursday, April 14, 2022, at 3:00 p.m. ET / 12:00 p.m. PT.

In the United States, five out of every 1,000 children suffer from hearing loss. After accounting for immigrant children from Mexico and China, that figure increases by at least 7.5 percent.

Synairgen plc, the respiratory company developing SNG001, an investigational formulation for inhalation containing the broad-spectrum antiviral protein interferon beta, announces that further analysis of its Phase 3 SPRINTER trial data will be presented at the ATS 2022 International Conference, being held between 13-18 May 2022 in San Francisco.

AVROBIO to Present at the 21st Annual Needham Virtual Healthcare Conference.

Takeda and the New York Academy of Sciences Announce 2022 Innovators in Science Award Winners.

Bruker Acquires Optimal Companies for Pharma PAT Software and Biopharma Manufacturing Automation Expertise and Technologies.